Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
Clinical trial NCT02733094 · COMPLETED
Trial details
- NCT number
- NCT02733094
- Sponsor
- Technical University of Munich
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-09-10
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.